ABERA — Abera Bioscience AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK115.88m
- SEK92.39m
Annual balance sheet for Abera Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 12 | 15.4 | 3.3 | 6.09 | 23.5 |
| Net Total Receivables | 0.295 | 0.766 | 0.765 | 0.65 | 0.985 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 29.5 | 17.7 | 7.44 | 10.6 | 25.4 |
| Net Property, Plant And Equipment | — | — | — | 1.07 | 1.3 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 31.4 | 19.6 | 9.35 | 13.6 | 28.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.22 | 2.8 | 3.69 | 4.95 | 9.28 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.22 | 2.8 | 3.69 | 4.95 | 9.28 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 29.2 | 16.8 | 5.66 | 8.66 | 19.3 |
| Total Liabilities & Shareholders' Equity | 31.4 | 19.6 | 9.35 | 13.6 | 28.6 |
| Total Common Shares Outstanding |